Conversion of bone marrow mesenchymal stem cells into type II alveolar epithelial cells reduces pulmonary fibrosis by decreasing oxidative stress in rats

Pulmonary fibrosis is an irreversible chronic progressive fibroproliferative lung disease, which usually has a poor prognosis. Previous studies have confirmed that the transplantation of bone marrow mesenchymal stem cells (MSCs) significantly reduces lung damage in a number of animal models. However...

Descripción completa

Detalles Bibliográficos
Autores principales: HUANG, KUN, KANG, XIAOWEN, WANG, XINYAN, WU, SHIJIE, XIAO, JINLING, LI, ZHAOGUO, WU, XIAOMEI, ZHANG, WEI
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2015
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4270324/
https://www.ncbi.nlm.nih.gov/pubmed/25411925
http://dx.doi.org/10.3892/mmr.2014.2981

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4270324/
https://www.ncbi.nlm.nih.gov/pubmed/25411925
http://dx.doi.org/10.3892/mmr.2014.2981

Ejemplares similares